Clinical Trial: Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519278) titled 'Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects' on April 02.

Brief Summary: The study compared pramipexole dihydrochloride extended-release tablets (Test produce) by Haisco Pharmaceutical Group Co., Ltd. with the reference produce (MIRAPEX ER(R)，Boehringer Ingelheim GmbH of Germany) to evaluate the bioequivalence of single dose in Chinese healthy subjects under fasting and fed conditions.

Study Start Date: March 16, 2017

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Test formulation（pramipexole dihydrochloride extended-release tablets&...